SkyCell focuses on developing temperature controlled logistics containers for the pharmaceutical industry.
SkyCell has raised $59.0M in total funding. The most recent round was Series D. The last funding was announced in June 2024.
SkyCell's investors include M&G Investments, Shuaa Capital psc, MVM Life Science Partners, Lazard Asset Management, BCGE.
SkyCell is headquartered in Zurich, Switzerland.
SkyCell focuses on developing temperature controlled logistics containers for the pharmaceutical industry.
SkyCell is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SkyCell — Funding & Investors." VCBacked, June 25, 2024, https://www.vcbacked.co/company/skycell. Accessed October 29, 2026.
VCBacked. (2024). SkyCell — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/skycell
{{cite web |title=SkyCell — Funding & Investors |url=https://www.vcbacked.co/company/skycell |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated